NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Ramanan AV, Dick AD, Jones AP, et al. Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT. Southampton (UK): NIHR Journals Library; 2019 Apr. (Health Technology Assessment, No. 23.15.)
Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT.
Show details- AC
anterior chamber
- ACR
American College of Rheumatology
- A&E
accident and emergency
- AE
adverse event
- AIC
Akaike information criterion
- CHAQ
Childhood Health Assessment Questionnaire
- CHQ
Childhood Health Questionnaire
- CI
confidence interval
- CR
credible range
- CRF
case report form
- CTRC
Clinical Trials Research Centre
- DIC
deviance information criterion
- DMARD
disease-modifying antirheumatic drugs
- GFR
glomerular filtration rate
- GP
general practitioner
- HR
hazard ratio
- HRG
Healthcare Resource Group
- HUI
Health Utilities Index
- HUI2
Health Utility Index Mark 2
- HUI3
Health Utility Index Mark 3
- ICER
incremental cost-effectiveness ratio
- IDSMC
Independent Data and Safety Monitoring Committee
- IMP
investigational medicinal product
- IOP
intraocular pressure
- ITT
intention to treat
- JADAS
Juvenile Arthritis Disease Activity Score
- JIA
juvenile idiopathic arthritis
- LMM
linear missed model
- logMAR
logarithm of the minimum angle of resolution
- MTX
methotrexate
- PAS
patient administration systems
- PhS
physical subscale
- PLICS
patient-level information and costing systems
- PsS
psychosocial subscale
- QALY
quality-adjusted life-year
- RF
rheumatoid factor
- RR
relative risk
- SAE
serious adverse event
- SAP
statistical analysis plan
- SAS PROC
Statistical Analysis Systems Procedure
- SD
standard deviation
- SE
standard error
- SUN
Standardisation of Uveitis Nomenclature
- SYCAMORE
a randomised controlled trial of the clinical effectiveness, SafetY and Cost-effectiveness of Adalimumab in Combination with MethOtRExate for the treatment of juvenile idiopathic arthritis associated uveitis
- TMG
Trial Management Group
- TNF-α
tumour necrosis factor alpha
- TSC
Trial Steering Committee
- VI
visual impairment
- List of abbreviations - Adalimumab in combination with methotrexate for refracto...List of abbreviations - Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
- Clinical effectiveness results: open-label phase - Adalimumab in combination wit...Clinical effectiveness results: open-label phase - Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT
- Gm37210 AND (alive[prop]) (0)Gene
- LOC101973161 [Ictidomys tridecemlineatus]LOC101973161 [Ictidomys tridecemlineatus]Gene ID:101973161Gene
Your browsing activity is empty.
Activity recording is turned off.
See more...